Test Directory
| Test Code | |||
| POMEA | |||
| Test Name | |||
| Pompe Disease (GAA) Activity in Leukocytes | |||
| CPT Codes | |||
| 82657 | |||
| Expected Turnaround Time | |||
| 3 - 7 days | |||
| Clinical Utility | |||
|
This test is useful for the diagnosis of Pompe disease and provides diagnostic testing for individuals with decreased alpha-glucosidase activity on newborn screen or clinical signs and symptoms suspicious for Pompe disease. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Whole Blood Preferred Collection Container: Pale Yellow Top (ACD solution B) Alternate Collection Container: Pale Yellow Top (ACD solution A) or Lavender Top (EDTA) Desired Specimen Volume: 6 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
Submit specimen with Biochemical Genetics Patient Information form.
|
|||
| Transport Instructions | |||
|
Transport to the laboratory refrigerated. |
|||
| Stability Requirements | |||
|
|||
| Causes for Rejection | |||
|
|||
| Methodology | |||
| Liquid Chromatography - Tandem Mass Spectrometry (LC-MS/MS) | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Limitations | |||
|
Pseudodeficiency results in low measured acid alpha-glucosidase activity, but it is not consistent with Pompe disease. Molecular analysis (GAAN / Pompe Disease, GAA Gene Sequencing with Deletion/Duplication, Varies) should be performed to resolve the clinical question. Additional biochemical or molecular testing is recommended to confirm a diagnosis if an enzyme deficiency is detected by this screening test. Enzyme levels may be normal in individuals receiving enzyme replacement therapy. |
|||
| Alternate Names | |||
|
|||
| Reference Lab | |||
| Mayo Clinic Laboratories | |||
| Testing Schedule | |||
| Varies | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.